TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Smerud Medical Research Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
257
|
188
|
58 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
100
|
52
|
-44 |
| EBITDA |
100
|
52
|
-44 |
| Total assets |
197
|
175
|
170 |
| Current assets |
197
|
175
|
170 |
| Current liabilities |
36
|
112
|
159 |
| Equity capital |
161
|
63
|
11 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.7%
|
36.0%
|
6.5% |
| Turnover per employee |
257
|
188
|
58 |
| Profit as a percentage of turnover |
38.9%
|
27.7%
|
-75.9% |
| Return on assets (ROA) |
50.8%
|
29.7%
|
-25.9% |
| Current ratio |
547.2%
|
156.2%
|
106.9% |
| Return on equity (ROE) |
62.1%
|
82.5%
|
-400% |
| Change turnover |
76
|
130
|
40 |
| Change turnover % |
42%
|
223%
|
214% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.